| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/30/2005 | CN1602309A Benzothiophenes as adenosine receptor modulators |
| 03/30/2005 | CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents |
| 03/30/2005 | CN1602306A Preparation of trans-fused 3, 3a, 8, 12b-tetrahydro-2h-dibenzo[3, 4:6, 7]cyclohepta[1, 2-b]furan derivatives |
| 03/30/2005 | CN1602292A Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 03/30/2005 | CN1602206A Pharmaceutical compositions based on azetidine derivatives |
| 03/30/2005 | CN1602203A Use of gp130 activators in diabetic neuropathy |
| 03/30/2005 | CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/30/2005 | CN1602193A Beverage treated with nicotine |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution |
| 03/30/2005 | CN1600360A Soft capsule of decoction of four ingredients possessing effect of enriching blood and regulating menstruation and preparation method |
| 03/30/2005 | CN1600351A Medication for treating peripheral nervous lesion caused by diabetes |
| 03/30/2005 | CN1600350A Capsule of activating the channels for cervical vertebrae |
| 03/30/2005 | CN1600349A Capsule prepared from cicada for soothing the nerves at night |
| 03/30/2005 | CN1600336A Sobering up extraction |
| 03/30/2005 | CN1600333A Painkiller |
| 03/30/2005 | CN1600327A External pasted medication for curing nervus vascularis headache and perparation method of production |
| 03/30/2005 | CN1600314A Injection for venocylsis of diluted Diltiazem containing calcium channel blocker |
| 03/30/2005 | CN1600309A Stable injection solution of freeze drying powder of lappaconite hydrobromide and preparation |
| 03/30/2005 | CN1600299A Compound tablet of tramadol hydrochloride dispersion |
| 03/30/2005 | CN1194987C Purified polypeptide with bioactiveity and medicine preparied from it for promoting growth and and development of animal's nerve cells and suppressing their apotosis |
| 03/30/2005 | CN1194982C Structure of phenethyl alcohol glycoside compound and its use |
| 03/30/2005 | CN1194762C Gene therapy for cerebrovasclar disorders |
| 03/30/2005 | CN1194753C Medicine for treating head wind syndrome |
| 03/30/2005 | CN1194742C Chinese medicinal composition with delaying senility and improving sleep functions, and preparing method thereof |
| 03/30/2005 | CN1194728C Pellet capable of curing infantile anorexia and convulsion |
| 03/30/2005 | CN1194725C Apoplexia hemiplegic recovered capsule and preparing method thereof |
| 03/30/2005 | CN1194694C Sustained relcase maclobemide capsule |
| 03/30/2005 | CN1194693C Application of paralytic PSP toxin in preparing antalgesic medicine |
| 03/29/2005 | US6872853 Bioavailability; reacting sertratineamine with hydrogen chloride |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 03/29/2005 | US6872833 Alzheimer's disease; Parkinson's disease; antidepressants |
| 03/29/2005 | US6872746 Isomeric fused pyrrolocarbazoles and isoindolones |
| 03/29/2005 | US6872744 Analgesics |
| 03/29/2005 | US6872741 Sodium channel modulators |
| 03/29/2005 | US6872740 4-(heteroarylethyl)-4,5-dihydro-1,3-thiazol-2-ylamine or salt, useful for treating an illness, which involves an abnormal production of nitric oxide (NO) by induction of an inducible NO-synthase |
| 03/29/2005 | US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/29/2005 | US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis |
| 03/29/2005 | US6872733 Benzimidazolone compounds |
| 03/29/2005 | US6872731 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 03/29/2005 | US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 03/29/2005 | US6872728 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 03/29/2005 | US6872720 Pyrazolo-triazine derivatives as ligands for gaba receptors |
| 03/29/2005 | US6872719 Antiinflammatory agents; autoimmune disease |
| 03/29/2005 | US6872718 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 03/29/2005 | US6872717 Pharmacological uses of azetidine derivatives |
| 03/29/2005 | US6872716 Sexual diosrders; schizophrenia; drug abuse; eating disorders anxiolytic agents |
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/29/2005 | US6872554 For therapy of Alzheimer's disease; immunization |
| 03/29/2005 | US6872408 Administering isotopically pure heavy water, carbonate or phosphate either containing deuterium and no hydrogen or hydrogen and no deuterium |
| 03/29/2005 | US6872397 Administering to the patient a therapeutical amount of botulinum toxin of a selected serotype until patient experiences loss of clinical response to the toxin and then administering another botulinum toxin of a different serotype |
| 03/29/2005 | US6872381 Such as 1-(5-chloro-2-(2-((2R)-4-(4-fluoro-18F-benzyl)-2-methylpiperazin-1-yl)-2 -oxoethoxy)phenyl)urea for binding chemokine receptors in brain tissue; tomography |
| 03/29/2005 | CA2392879C A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders |
| 03/29/2005 | CA2335186C Pyrrolo[2,3-d]pyrimidine compounds |
| 03/29/2005 | CA2280447C Pyrrolo¬1,2-a|pyrazine derivatives as 5ht1a ligands |
| 03/29/2005 | CA2268870C Heterocyclic carboxamides |
| 03/29/2005 | CA2173505C Use of penciclovir for the treatment of post-herpetic neuralgia |
| 03/24/2005 | WO2005026343A1 Method of promoting subsistence and/or proliferation of neural stem cell and promoting extension of neurite, promoter therefor, pharmaceutical composition containing neural stem cell, method of assay and method of screening |
| 03/24/2005 | WO2005026177A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 03/24/2005 | WO2005026170A2 Uses of neuronal pannexins for therapy and diagnosis in mammals |
| 03/24/2005 | WO2005026166A1 Physiologically active composition, pharmaceutical composition, substituted 1,2-dihydro[2,7] naphthyridines, method for the production and use thereof |
| 03/24/2005 | WO2005026138A1 2-naphthylimino-1,3-thiazine derivative |
| 03/24/2005 | WO2005026125A1 Quinoline compounds and pharmaceutical compositions containing them |
| 03/24/2005 | WO2005026117A1 Preventive for cerebral stroke recurrence |
| 03/24/2005 | WO2005025675A1 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
| 03/24/2005 | WO2005025621A1 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness |
| 03/24/2005 | WO2005025616A1 Use of antibody |
| 03/24/2005 | WO2005025610A1 Use of markk or markk antagonists for the treatment of pathologies characterised by increased or reduced phosphorylation of mark or tau protein |
| 03/24/2005 | WO2005025576A1 7-heteroarylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents |
| 03/24/2005 | WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 03/24/2005 | WO2005025569A1 Use of known active ingredients as radical scavengers |
| 03/24/2005 | WO2005025563A1 Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
| 03/24/2005 | WO2005025487A2 Oligonucleotides targeting prion diseases |
| 03/24/2005 | WO2005016325A3 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF |
| 03/24/2005 | WO2005000806A3 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004096269A3 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors |
| 03/24/2005 | WO2004096231A3 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 03/24/2005 | WO2004080382A3 Novel compositions containing fentanyl |
| 03/24/2005 | WO2004078756A3 Jnk inhibitors |
| 03/24/2005 | WO2004064869A3 Amyloid-binding, metal-chelating agents |
| 03/24/2005 | WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/24/2005 | WO2004046113A3 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 03/24/2005 | WO2004018482A8 C6- and c9-substituted chromeno[4, 3-c]isoxazoline derivatives and their use as anti-depressants |
| 03/24/2005 | WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/24/2005 | WO2004000197A3 Quick dissolve compositions and tablets based thereon |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065348 Pyridin-2-yl-methylamine derivatives for treating opioid dependence |
| 03/24/2005 | US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia |
| 03/24/2005 | US20050065219 Treatment of demyelinating conditions |
| 03/24/2005 | US20050065218 Metabolites; or synergistic mixture with imipramine or fluoxetine |
| 03/24/2005 | US20050065207 Method for the preparation of escitalopram |
| 03/24/2005 | US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065193 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 03/24/2005 | US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission |